We serve Chemical Name:3-(2-phenylethynyl)-1-benzofuran-5-carbaldehyde CAS:648449-51-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-(2-phenylethynyl)-1-benzofuran-5-carbaldehyde
CAS.NO:648449-51-8
Synonyms:3-(2-phenylethynyl)-1-benzofuran-5-carbaldehyde
Molecular Formula:C17H10O2
Molecular Weight:246.26000
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:30.21000
Exact Mass:246.06800
LogP:3.64510
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-(2-phenylethynyl)-1-benzofuran-5-carbaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(2-phenylethynyl)-1-benzofuran-5-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(2-phenylethynyl)-1-benzofuran-5-carbaldehyde Use and application,3-(2-phenylethynyl)-1-benzofuran-5-carbaldehyde technical grade,usp/ep/jp grade.
Related News: Developed in collaboration with the sector, including academia, industry and charities with organizations such as Universities UK and GSK, (S)-2-(2-(5-bromopyridin-3-yl)acetamido)-N-(5-methylthiazol-2-yl)pentanamide manufacturers As further tools are created to improve biocatalyst development, these can likewise be assessed for their capacity to add value to a project. N,N-dibenzyl-4-(5,6-dimethoxy-2H-benzo[d][1,2,3]triazol-2-yl)aniline suppliers For these reasons, many pharmaceutical companies are choosing to evaluate biocatalytic processes during early-stage drug development to avoid missing opportunities for capitalizing on these gains. 2-Chloro-4-[(E)-4-iodo-phenylimino]-cyclohexa-2,5-dienone vendor & factory Developed in collaboration with the sector, including academia, industry and charities with organizations such as Universities UK and GSK, ,As further tools are created to improve biocatalyst development, these can likewise be assessed for their capacity to add value to a project.